Neoadjuvant chemotherapy with atezolizumab, bevacizumab, and FOLFOX for patients with unresectable colorectal liver metastases: A translational pilot study

被引：0
|
作者：
Kim, Sun Young
Kim, Wonkyung
Sung, Chang Ohk
Kim, Jihun
Hong, Yong Sang
Kim, Jeong Eun
Kim, Tae Won
机构：
[1] Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
[3] Univ Ulsan, Dept Pathol, Coll Med, Asan Med Ctr, Seoul, South Korea
[4] Univ Ulsan, Dept Oncol, Asan Med Ctr, Coll Med, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3573
引用
收藏
页数：1
相关论文
共 50 条
  • [1] FOLFOX/FOLFIRI-Bevacizumab for Unresectable Colorectal Liver Metastases
    Franko, Jan
    Le, Viet H.
    JAMA ONCOLOGY, 2025, 11 (01) : 13 - 15
  • [2] Effectiveness of neoadjuvant FOLFOX chemotherapy in Japanese patients with colorectal cancer liver metastases
    Baba, H.
    Beppu, T.
    Honda, S.
    Yoshida, N.
    Komori, H.
    Hayashi, N.
    Toyama, E.
    Horino, K.
    Miyanari, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Liver resection after neoadjuvant chemotherapy for unresectable colorectal metastases
    Noguera, J.
    Arrivi, A.
    Vicens, J.
    Morales, R.
    Ibarra, J.
    Dolz, C.
    Pujol, J.
    ANNALS OF ONCOLOGY, 2006, 17 : 57 - 57
  • [4] Chemotherapy Plus Bevacizumab as Neoadjuvant or Conversion Treatment in Patients with Colorectal Liver Metastases
    Garcia Alfonso, Pilar
    Cavanagh Podesta, Mercedes
    Munoz Martin, Andres
    Blanco Codeisido, Montserrat
    Calvo, Aitana
    Peligros, Isabel
    Corcuera, Ana
    Ruperez Blanco, Ana Belen
    Custodio-Cabello, Sara
    Lopez Trabada, Daniel
    Martin, Miguel
    De Ramon, Enrique
    ANTICANCER RESEARCH, 2018, 38 (05) : 3069 - 3077
  • [5] Modified FOLFOX6 and Bevacizumab As Neoadjuvant Chemotherapy for Patients With Potentially Curable Bilobar Liver Metastases From Colorectal Cancer
    Maeda, Atsuyuki
    Isogai, Masatoshi
    Kaneoka, Yuji
    GASTROENTEROLOGY, 2013, 144 (05) : S1079 - S1079
  • [6] Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma
    Leonard, GD
    Brenner, B
    Kemeny, NE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) : 2038 - 2048
  • [7] Effectiveness of neoadjuvant chemotherapy including bevacizumab in patients with resectable colorectal cancer liver metastases
    Gruenberger, B.
    Scheithauer, W.
    Tamandl, D.
    Zielinski, C.
    Schueller, J.
    Gruenberger, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] The pathological response to neoadjuvant chemotherapy with FOLFOX-4 for colorectal liver metastases: a comparative study
    Mark M. Aloysius
    Abed M. Zaitoun
    Ian J. Beckingham
    Keith R. Neal
    Guruprasad P. Aithal
    Eric M. Bessell
    Dileep N. Lobo
    Virchows Archiv, 2007, 451 : 943 - 948
  • [9] The pathological response to neoadjuvant chemotherapy with FOLFOX-4 for colorectal liver metastases: a comparative study
    Aloysius, Mark M.
    Zaitoun, Abed M.
    Beckingham, Ian J.
    Neal, Keith R.
    Aithal, Guruprasad P.
    Bessell, Eric M.
    Lobo, Dileep N.
    VIRCHOWS ARCHIV, 2007, 451 (05) : 943 - 948
  • [10] MULTICENTER PHASE II STUDY OF FOLFOX6 AS NEOADJUVANT CHEMOTHERAPY FOR PATIENTS WITH UNRESECTABLE LIVER-ONLY METASTASES FROM COLORECTAL CANCER IN JAPAN; ROOF STUDY
    Shibata, Y.
    Takahashi, T.
    Tojima, Y.
    Tsuboi, K.
    Sakamoto, E.
    Kunieda, K.
    Matsuoka, H.
    Suzumura, K.
    Sakamoto, J.
    Kondo, K.
    ANNALS OF ONCOLOGY, 2010, 21 : 220 - 220
12345